News Sentiment

SOPH sentiment intelligence

Sophia Genetics SA news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 46 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Health Information Services Read-through group
Latest close 5.46 Week of 19 Jun 2026
Weighted tone 52/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

91/100 classification confidence.

Company focus 46

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

+11.9% over one week, +11.9% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Director Troy Cox receives new SOPHiA GENETICS (SOPH) RSU and option grants

Market Reaction

Price moving ahead of tone

64/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 91/100 classification
One-week reaction 11.9% Price confirming higher
Trend fit Trend active 11.9% over four weeks
Fair value 35.7% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 10
Neutral 26
Negative 10

Relevance

Why the article matched

Direct first
Direct company coverage 46
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 20
GuruFocus 4
MT Newswires 4
PR Newswire 3
Investing.com 2
MarketBeat 2
marketscreener.com 2
Startupticker.ch 1

Event Lens

What the news is about

Classified themes
Market update 41
Earnings 4
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 46
Stock Titan Direct company coverage

SOPHiA GENETICS SA Current Report (Foreign Issuer) | SOPH SEC Filing - Form 6-K

SOPHiA GENETICS SA (SOPH) has filed a Form 6-K reporting the completion of an underwritten public offering of 12,104,900 ordinary shares at $4.75 per share, generating gross proceeds of approximately $57.5 million. The offering, which closed on June 18, 2026, included the full ex

Tone
Positive 66/100
Event
Market update
Published
22 Jun 2026 13:28
Source
Stock Titan
Startupticker.ch Direct company coverage

SOPHiA GENETICS raises USD 57.5 million through a public offering

SOPHiA GENETICS, a leader in AI-driven precision medicine, successfully closed an oversubscribed public offering, raising $57.5 million. The company sold 12,104,900 ordinary shares at $4.75 each, with underwriters fully exercising their option for additional shares, signaling str

Tone
Positive 75/100
Event
Market update
Published
22 Jun 2026 07:11
Source
Startupticker.ch
Fidelity Direct company coverage

SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional Shares

SOPHiA GENETICS has successfully closed a public offering of ordinary shares, raising $57.5 million. The offering included the full exercise of the underwriters' option to purchase additional shares, indicating strong market interest and investor confidence in the company. This c

Tone
Positive 75/100
Event
Market update
Published
20 Jun 2026 01:39
Source
Fidelity
MSN Direct company coverage

SOPHiA GENETICS prices $50M public offering at $4.75 per share

SOPHiA GENETICS has announced the pricing of a public offering of 10,526,316 ordinary shares at $4.75 per share, aiming to raise approximately $50 million before deductions. The offering is expected to close around June 21, 2024, and includes an option for underwriters to purchas

Tone
Neutral 50/100
Event
Market update
Published
19 Jun 2026 00:40
Source
MSN
GuruFocus Direct company coverage

Insider Sell: Zhenyu Xu Sells 4,000 Shares of Sophia Genetics SA

Zhenyu Xu, the Chief Scientific Officer of Sophia Genetics SA, sold 4,000 shares of the company on June 15, 2026, reducing his total holdings to 622,280 shares. This transaction is part of a larger trend of insider selling at Sophia Genetics SA, with 57 insider sells against only

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 01:09
Source
GuruFocus
Stock Titan Direct company coverage

SOPHiA GENETICS (SOPH) offers 10.53M shares; underwriters may add 1.58M

SOPHiA GENETICS has announced an offering of 10.526 million ordinary shares at $4.75 per share, aiming to raise gross proceeds of approximately $49.998 million. Underwriters have an option to purchase an additional 1.578 million shares. The net proceeds, estimated at $45.9 millio

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 21:09
Source
Stock Titan
Stock Titan Direct company coverage

SOPHiA GENETICS (SOPH) CSO sells 4,000 shares under 10b5-1 plan

SOPHiA GENETICS (SOPH) Chief Scientific Officer Xu Zhenyu sold 4,000 Ordinary Shares in an open-market transaction under a pre-arranged 10b5-1 trading plan. The shares were sold at a weighted average price of $5.0141, ranging from $4.90 to $5.13 per share. Following this transact

Tone
Negative 37/100
Event
Market update
Published
17 Jun 2026 20:09
Source
Stock Titan
Quantisnow Direct company coverage

SOPHiA GENETICS Announces Proposed Public Offering of Ordinary Shares

SOPHiA GENETICS has announced a proposed public offering of its ordinary shares. This news was alerted to Quantisnow Plus members shortly after publication. Quantisnow, a market data and news platform, provides real-time alerts on various financial events including press releases

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 00:09
Source
Quantisnow
Stock Titan Direct company coverage

SOPHiA GENETICS (NASDAQ: SOPH) files supplement for share offering; $5.01 last trade

SOPHiA GENETICS has filed a preliminary prospectus supplement for an ordinary share offering, which includes a 30-day option for underwriters to purchase additional shares. The company reported 71,790,366 ordinary shares outstanding as of March 31, 2026, with a last reported Nasd

Tone
Neutral 50/100
Event
Market update
Published
16 Jun 2026 21:39
Source
Stock Titan
Stock Titan Direct company coverage

SOPHiA GENETICS plans new stock sale with option for 15% more shares

SOPHiA GENETICS (Nasdaq: SOPH) announced a proposed underwritten public offering of its ordinary shares, with an option for underwriters to purchase an additional 15% of shares. All shares will be newly issued by the company, and the offering's size, price, and timing are subject

Tone
Negative 40/100
Event
Market update
Published
16 Jun 2026 20:39
Source
Stock Titan
Investing.com Direct company coverage

SOPHiA GENETICS stock falls on share offering announcement

SOPHiA GENETICS SA (NASDAQ:SOPH) shares fell in after-hours trading after the company announced a proposed underwritten public offering of its ordinary shares. The healthcare technology company plans to sell ordinary shares, with an option for underwriters to purchase an addition

Tone
Negative 28/100
Event
Market update
Published
16 Jun 2026 20:39
Source
Investing.com
GuruFocus Direct company coverage

Insider Sell: Philippe Menu Sells 5,000 Shares of Sophia Genetics SA

Philippe Menu, Chief Medical Officer of Sophia Genetics SA (SOPH), sold 5,000 shares on June 12, 2026, reducing his total holdings to 245,780 shares. This transaction is part of a trend for Sophia Genetics, which has seen 1 insider buy compared to 56 insider sells over the past y

Tone
Negative 37/100
Event
Market update
Published
15 Jun 2026 23:39
Source
GuruFocus
Stock Titan Direct company coverage

SOPHiA GENETICS (SOPH) CMO sells 5,000 shares under Rule 10b5-1 plan

SOPHiA GENETICS SA's Chief Medical Officer, Philippe Menu, sold 5,000 Ordinary Shares in an open-market transaction at a weighted average price of $4.9504 per share. This transaction was conducted under a pre-arranged Rule 10b5-1(c) trading plan, indicating it was scheduled in ad

Tone
Negative 39/100
Event
Market update
Published
15 Jun 2026 20:10
Source
Stock Titan
GuruFocus Direct company coverage

Insider Sell Alert: Jurgi Camblong Sells 8,500 Shares of Sophia Genetics SA (SOPH)

Jurgi Camblong, CEO of Sophia Genetics SA (SOPH), sold 8,500 shares of the company on June 10, 2026, bringing his total holdings to 3,620,995 shares. Sophia Genetics, specializing in AI-driven data analysis for healthcare, has seen significantly more insider selling than buying o

Tone
Negative 36/100
Event
Market update
Published
12 Jun 2026 10:10
Source
GuruFocus
MarketBeat Direct company coverage

Jurgi Camblong Sells 8,500 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock

SOPHiA GENETICS CEO Jurgi Camblong sold 8,500 shares of SOPH stock on June 10th for $44,540, following several similar transactions in March and April. This sale reduces his direct ownership by 0.23% to 3,620,995 shares, valued at approximately $18.97 million. The company's stock

Tone
Negative 42/100
Event
Market update
Published
11 Jun 2026 21:36
Source
MarketBeat
Stock Titan Direct company coverage

SOPHiA GENETICS (SOPH) CEO sells 8,500 shares under 10b5-1 plan

SOPHiA GENETICS SA CEO Jurgi Camblong sold 8,500 Ordinary Shares at a weighted average price of $5.2354 per share. The sale was executed under a Rule 10b5-1(c) trading plan. Following this transaction, Camblong directly holds 3,620,995 shares.

Tone
Negative 39/100
Event
Market update
Published
11 Jun 2026 19:39
Source
Stock Titan